MedTrace Logo

Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients

NCT05006105 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2022-09-16

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the added value of mobile health (mHealth) to detect atrial fibrillation (AF) early in the care path of cryptogenic stroke and transient ischemic attack (TIA) patients.

Conditions

Interventions

DEVICE

seven-day ECG Holter

Participants receive a seven-day ECG Holter after hospital discharge.

DEVICE

24-hour blood pressure monitor

Participants receive a 24-hour blood pressure monitor, approximately four weeks after hospital discharge.

OTHER

Questionnaire: vision of mHealth

Participants receive a questionnaire concerning their vision of mHealth, approximately four weeks after hospital discharge.

OTHER

Questionnaire: user experience & feeling of safety

Participants receive a questionnaire concerning their user experience and feeling of safety of using mHealth, after using mHealth for six months.

DEVICE

Insertable loop recorder

Participants receive an insertable loop recorder, approximately six weeks after hospital discharge.

Sponsors & Collaborators

  • Hasselt University

    collaborator OTHER

  • Jessa Hospital

    collaborator OTHER

  • Ziekenhuis Oost-Limburg

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006105 on ClinicalTrials.gov